Emerald Cloud Lab
Americas
Austin
,
United States
Scaleup
FOUNDED
2012
HEADCOUNT
101-500
FUNDING
Series C
Keywords:
laboratory_automation, data_handling, biofoundry
BUSINESS
Emerald Cloud Lab operates a fully automated, remotely accessible life sciences laboratory equipped with over 200 instrument models, controlled via a unified software interface (ECL Command Center). Scientists design, execute, and analyze experiments remotely from anywhere via the internet. The facility operates 24/7/365. The company acquired Strateos (formerly Transcriptic) in 2022, consolidating the two leading cloud lab platforms. Backed by Founders Fund (Series C stage). ECL has partnered with Carnegie Mellon University to build a $40 million academic cloud lab. The US Senate introduced the "Cloud LAB Act of 2025" (S.2676) to establish a national cloud laboratory network, reflecting federal interest in the concept. Customers span pharma, biotech, consumer products, and academic research.
BIOTECH INVOLVEMENT
The platform supports a wide range of experiments relevant to industrial biotechnology including protein characterization, enzyme assays, analytical chemistry, cell-free expression, PCR/qPCR, chromatography, mass spectrometry, and flow cytometry. The automated, software-defined nature of experiments generates structured, reproducible datasets that feed into AI/ML-driven design cycles for strain and enzyme engineering programs.
TECHNOLOGY PLATFORM
robotic automation; cloud lab platform; SmartLab software
PRIMARY PRODUCTS
Robotic cloud laboratories; lab automation platform